All articles tagged with #weight loss shots
Hims & Hers Health Inc. is committed to selling affordable weight-loss injections despite Novo Nordisk ending their partnership over alleged deceptive marketing of compounded versions of Wegovy, with Hims denying any wrongdoing and emphasizing their legal compliance and focus on customer access.
Weight-loss drugs like Ozempic and Mounjaro, known as GLP-1 inhibitors, are showing promise in helping women with polycystic ovarian syndrome (PCOS) conceive. While these drugs are not approved for treating infertility, anecdotal evidence and some doctors suggest that they may have a positive side effect of improving fertility in women with PCOS. PCOS affects about 10% of women of childbearing age and is characterized by infertility, weight gain, irregular menstrual cycles, and other symptoms. Weight loss is often recommended for PCOS patients, but it can be challenging. GLP-1 inhibitors may help regulate menstrual cycles, improve chances of conception, and alleviate other symptoms associated with PCOS. However, more research is needed to determine the safety and efficacy of these drugs for fertility purposes.
Weight loss shots like Wegovy, which contain the drug semaglutide, are gaining popularity for their ability to mimic a hormone that regulates appetite and food intake. In a study, participants who received Wegovy lost about 15% of their body weight, while those who received a placebo lost an average of about 2.5%. However, the cost of the drug can be a challenge, with many insurance plans declining to cover it. Despite this, doctors say that weight loss drugs like Wegovy can be useful and complementary to other methods of obesity management and weight loss.